1. Home
  2. Stock quotes
  3. Orchard Therapeutics plc
  4. Financial Statements
  5. Income Statement
  6. Cost of Revenue
Orchard Therapeutics plc logo
Orchard Therapeutics plc ORTX
$ 4.93 1.02%
mail-toReport an Error

Quarterly report 2023-Q3
added 11-13-2023

report update icon

Orchard Therapeutics plc Cost of Revenue 2011-2024 | ORTX

Annual Cost of Revenue Orchard Therapeutics plc

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
6.77 M 226 K 857 K 805 K 422 K - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
6.77 M 226 K 1.82 M

Quarterly Cost of Revenue Orchard Therapeutics plc

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
1.74 M 2.19 M 367 K - 1.64 M 1.12 M 1.57 M - 226 K - - - 667 K 191 K - - 614 K - - - 280 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
2.19 M 191 K 965 K